Topiramate Impurity 13 | CAS 70834-19-4 - Request Quote
Topiramate Impurity 13
| SZ CAT No: | SZ-T003029 |
| CAS No | 70834-19-4 |
| Mol.F. | C9H16O6 |
| Mol.Wt. | 220.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Topiramate Impurity 13 is chemically (2R,3R,4R,5R)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)tetrahydrofuran-2,3,4-triol. Topiramate Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Topiramate Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Topiramate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 70834-19-4
Purchase 70834-19-4
Order 70834-19-4
Enquire 70834-19-4
price of 70834-19-4
70834-19-4 Supplier
70834-19-4 Manufacturer
70834-19-4 Exporter
buy high quality Topiramate Impurity 13
Purchase Topiramate Impurity 13
Topiramate Impurity 13 suppliers
Topiramate Impurity 13 manufacturers
Topiramate Impurity 13 price
Order Topiramate Impurity 13
Enquire Topiramate Impurity 13
Topiramate Impurity 13 cost
Topiramate Impurity 13 Supplier
Topiramate Impurity 13 Distributor
Topiramate Impurity 13 for Method Validation
Topiramate Reference Standard
Topiramate Impurity 13 for ANDA Filing
Topiramate Impurity 13 for Forced Degradation Studies
Topiramate Impurity 13 Identification Standards
Topiramate Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.